This year more than 40+ Israeli companies participated in Medica 2022 which was held during Nov. 14–17, 2022 at Düsseldorf, Germany. The main exhibitors were in Israeli pavilion in Hall 16 Stand J 20, 24, 38. Some of the companies were also showcasing their Products/ Technologies in Hall 5, Stands L 13. 

The Israel Export Institute’s Life Science Division along with Economic and Trade Missions from several countries assisted in business matching between the more than 40+ Israeli companies and worldwide business partners at all levels. It has a proven ability to participate in Healthcare Exhibitions worldwide and identify and match suitable potential business partners and likewise organized one-on-one business meetings during Medica 2022.

Israel as a leader of creative innovations in the world of high-tech, has become a leader of innovative solutions in the life science arena to meet today’s healthcare challenges to lower overall healthcare costs and the world’s evolving needs of aging population and providing better, higher quality medical care to the emerging middle classes in India and other developing countries.

The Israeli companies had a vast product range to offer in various therapeutic areas such Cardiology, Oncology, Neurology, Emergency Medicine, Rehabilitation, Ophthalmology, Gastrointestinal, Orthopedics and Sport Medicine, Women’s Health, Pain and Wound Management, Dermatology and Aesthetics. They offer a variety of innovative medical solutions and technologies that answer today’s healthcare challenges. Some of Israeli Exhibitors interested in Indian market were: B-Cure Laser, Better Air, BioXtreme, BrainsWay, BMT, Cardiac Sense, Eitan Group, iPulse Medical, Flight Medical, MedCu Technologies, NeoLaser, NanoVation, TytoCare, Virtual Ports and many more. 

Indian Healthcare Sector:

Healthcare delivery in India witnessed a renewed focus on leveraging digital technology during the Covid pandemic. This sector, predominantly recognized for Sick care delivery, has looked at building the next-gen capabilities that will be a differentiator in the decade ahead. Several reforms launched before and during the pandemic such as National Health Digital Mission (NDHM), teleconsulting guidelines combined with burgeoning health tech start-up ecosystem enabled by innovation, have evolved to make the healthcare journey better for Indian population.

Maximizing the clinical, financial, and operational value of these new digital offerings and services requires Biopharma, Med-tech and other Healthcare stakeholders to reinforce digital as an entirely new business model and ecosystem to deliver better outcomes and drive stakeholder awareness, adoption, engagement, and growth. 

Healthcare has become one of India’s largest sectors – both in terms of revenue and employment. Healthcare comprises Hospitals, Medical devices, Clinical trials, Outsourcing, Telemedicine, Medical tourism, Health Insurance and Medical equipment. The Indian Healthcare sector is growing at a brisk pace due to its strengthening coverage, services and increasing expenditure by public as well private players. India’s competitive advantage lies in its large pool of well-trained medical professionals. India is also cost competitive compared to its peers in Asia and Western countries. The cost of surgery in India is about one-tenth of that in the US or Western Europe.

There is a significant scope for enhancing healthcare services considering that healthcare spending as a percentage of Gross Domestic Product (GDP) is rising. The Government of India is planning to increase public health spending to 2.5 per cent of the country’s GDP by 2025. 

Indian perspective:

From Indian perspective, Israeli Pavilion in Medica 2022 attracted many Indian Hospitals, Importers and distributors. Keeping in view the interests of Israeli companies more than 30 meetings were scheduled with Indian Importers and Distributors and there were around 120 on the spot meetings with new Indian companies. The Israeli companies explored strategic partnerships with Indian Stakeholders, allowing access to more innovative Medical Devices and Technologies and enhanced their ability to reach a larger Indian market.

The Indian companies were assisted in scheduling the meetings and came to Israeli Pavilion were Mankind Pharma, Medikraft, Vikas Medical, HLL, Abhinav Futuristic, DSS Imagetech, Lars Medicare Sanare Medical, Luthra Associates, Rohanika etc.

While at the Israeli Pavilion we were able to get attention of around 25+ new Indian companies which showed their interests and met Israeli companies. Some of them were Allengers, Apollo, KSP, Elite Medical, Falcon, Prajwal, Hero Eco Med, Med Plus, Tamar Healthcare, Medlife, GuviSurge, Med life, Lotus, AVI Healthcare, HOPS, Advance Life Sciences, Microgen, Miraclus, etc. The companies were interested in being the Importers and Distributors in India.

For more information please contact Mr. Tejinder Singh (